The joint venture comprises Croma's Hyaluronic Acid Filler Princess® VOLUME and additional filler and facial aesthetic products and CNBG's multi-channel distribution, marketing experience and synergistic products, specifically its botulinum toxin product Heng Li®.
Lead Product(s): Hyaluronic Acid
Therapeutic Area: Dermatology Product Name: Hyaluronic Acid Filler Princess
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: China National Biotech Group
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration September 15, 2020